Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2799267 | Diabetes Research and Clinical Practice | 2006 | 8 Pages |
Abstract
Long-term insulin glargine treatment plus OHAs provides continued glycaemic control and is well tolerated in patients with Type 2 diabetes. Therefore, insulin glargine appears to be suitable for the long-term management of Type 2 diabetes.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Gertrud Kacerovsky-Bielesz, Ansgar Dressler, Regina Freunscht,